Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance

Published:2011-12-01 Issue:51 Volume:108 Page:20509-20513
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Powdrill M. H.,Tchesnokov E. P.,Kozak R. A.,Russell R. S.,Martin R.,Svarovskaia E. S.,Mo H.,Kouyos R. D.,Gotte M.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference30 articles.

1. Global Burden of Disease (GBD) for Hepatitis C

2. Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

3. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

4. Treating Hepatitis C in “Difficult-to-Treat” Patients

5. Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections;International Journal of Molecular Sciences;2023-12-26

2. Molecular-genetic pathways of hepatitis C virus regulation of the expression of cellular factors PREB and PLA2G4C, which play an important role in virus replication;Vavilov Journal of Genetics and Breeding;2023-12-11

3. Exploration of Computational Aids for Effective Drug Designing and Management of Viral Diseases: A Comprehensive Review;Current Topics in Medicinal Chemistry;2023-08-07

4. Accelerating antiviral drug discovery: lessons from COVID-19;Nature Reviews Drug Discovery;2023-05-12

5. Drug Resistance in Antiviral Therapy;Viral Drug Delivery Systems;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3